Intranasal delivery of ESBA105, a TNF-alpha-inhibitory scFv antibody fragment to the brain
Authors:
- Valérie HulmannVHValérie Hulmann
- David M. UrechDUDavid M. Urech
- 1 October 2009
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 215 (1-2) , 65-72
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Inflammatory demyelinating events following treatment with anti-tumor necrosis factorCytokine, 2009
- Direct transport of VEGF from the nasal cavity to brainNeuroscience Letters, 2009
- Intranasally delivered TGF-β1 enters brain and regulates gene expressions of its receptors in ratsBrain Research Bulletin, 2007
- Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administrationNeuroscience, 2004
- Penetration enhancement effect of Pz-peptide, a paracellularly transported peptide, in rabbit intestinal segments and Caco-2 cell monolayersJournal of Controlled Release, 1995
- Tumor necrosis factor‐α messenger RNA expression in patients with relapsing‐remitting multiple sclerosis is associated with disease activityAnnals of Neurology, 1995
- Paracellular transport of a proteolytically labile pentapeptide across the colonic and other intestinal segments of the albino rabbit: implications for peptide drug designJournal of Controlled Release, 1994
- Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patientsNeuroscience Letters, 1994
- Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosisJournal of Neuroimmunology, 1991
- Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkeyJournal of Comparative Neurology, 1986